D
Lexicon Pharmaceuticals, Inc. LXRX
$1.15 $0.0151.33% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 28.87M 1.26M 26.55M 1.75M 1.65M
Total Other Revenue -- -- -- -- --
Total Revenue 28.87M 1.26M 26.55M 1.75M 1.65M
Cost of Revenue 1.65M 1.60M 25.93M 25.85M 1.85M
Gross Profit 27.21M -342.00K 621.00K -24.10M -198.00K
SG&A Expenses 9.35M 11.61M 21.06M 39.59M 39.19M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 25.13M 26.94M 46.99M 65.44M 57.00M
Operating Income 3.74M -25.68M -20.44M -63.69M -55.35M
Income Before Tax 3.25M -25.30M -33.77M -64.81M -53.43M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 3.25M -25.30M -33.77M -64.81M -53.43M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 3.25M -25.30M -33.77M -64.81M -53.43M
EBIT 3.74M -25.68M -20.44M -63.69M -55.35M
EBITDA 3.91M -25.50M -20.31M -63.57M -55.22M
EPS Basic 0.01 -0.07 -0.09 -0.18 -0.17
Normalized Basic EPS 0.01 -0.04 -0.04 -0.11 -0.11
EPS Diluted 0.01 -0.07 -0.09 -0.18 -0.17
Normalized Diluted EPS 0.01 -0.04 -0.04 -0.11 -0.11
Average Basic Shares Outstanding 363.29M 362.07M 361.49M 361.49M 310.84M
Average Diluted Shares Outstanding 363.57M 362.07M 361.49M 361.49M 310.84M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --